Q-omics provides the consensus-scored RPL13AP profile across patient tissues and cancer cell-line models. RPL13AP expression is associated with patient survival in 16 of 34 cancer types, with the highest sampling consensus in READ. Among the 18 cancer types available for tumor–normal comparison, RPL13AP is differentially expressed in 1, with the highest sampling consensus in THCA. Additionally, RPL13AP RNA expression shows 6,056 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight READ, THCA, and STAD as cancer lineages where RPL13AP shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for RPL13AP — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes RPL13AP survival associations across molecular data types. RPL13AP RNA expression shows survival associations in the most cancer types (16). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible RPL13AP RNA expression–survival associations across cancer types. High RPL13AP expression shows unfavorable associations in CHOL, ACC and LGG, but favorable associations in READ, THCA and KIRC. The READ Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p = .003). Together, the overview and detailed table identify READ as the clearest survival context for RPL13AP RNA expression.
This table summarizes RPL13AP tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 1. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for RPL13AP. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. RPL13AP shows higher tumor expression in THCA. The THCA box plot shows higher RPL13AP RNA expression in tumor versus normal tissue (log2 FC = +0.076, t-test p < 0.001).
This table shows molecular features associated with RPL13AP in patient tissues and cancer cell lines. In patient samples, RPL13AP shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.
